EMPAPHAGE-M 12.5+500MG 14S TAB

Empaphage-M is a combination therapy for type-2 diabetes containing Empagliflozin 12.5 mg (an SGLT-2 inhibitor) and Metformin 500 mg (a biguanide). It helps lower blood glucose by increasing glucose excretion through urine and improving the body’s response to insulin. It supports long-term blood sugar control while offering added benefits for cardiovascular and kidney health in diabetes patients.

Uses

• Helps control Type-2 Diabetes Mellitus.

• Used when diet, exercise, or single medication are not enough for glucose control.

• Helps lower risk of diabetes-related heart and kidney complications.

Benefits

• Dual action: reduces liver glucose production + increases urinary glucose removal.

• Helps with better HbA1c reduction and daily glucose stability.

• May assist in weight loss and reduce blood pressure slightly.

• Supports heart and kidney protection in diabetic patients.

• Convenient dosing in a single tablet for better adherence.

Side Effects

• Common: increased urination, nausea, stomach upset, diarrhea, dizziness, thirst.

• Possible: urinary tract or genital infections (due to more glucose in urine), dehydration, low blood sugar when combined with other diabetes drugs.

• Rare but serious: ketoacidosis symptoms (nausea, vomiting, difficulty breathing), severe kidney issues — seek urgent care if these occur.

Precautions

• Only for Type-2 diabetic adults; not for Type-1 diabetes or diabetic ketoacidosis.

• Maintain good hydration to avoid dehydration and dizziness.

• Inform your doctor if you have kidney issues, recurrent UTIs, liver disease, or heart failure.

• Avoid excessive alcohol to reduce lactic acidosis risk.

• Monitor blood sugar regularly and follow diet/exercise plan as advised.

• Not recommended during pregnancy or breastfeeding unless prescribed.